Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The two blockbusters Novo Nordisk medicines are among 15 additional drugs whose prices Medicare will be allowed to negotiate ...

For example, a Senate hearing earlier this year found that U.S. residents pay $969 a month for Ozempic. Under a policy announced by the White House earlier this year, Medicare and Medicaid will ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

At the top of the list is Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot ... regardless of why they are prescribed. Medicare does not currently cover Wegovy for weight ...